Last updated: 25 July 2024 at 7:36pm EST

Raymond Cohen Net Worth




The estimated Net Worth of Raymond W Cohen is at least $55.8 Million dollars as of 24 July 2024. Mr. Cohen owns over 103,896 units of Axonics Inc stock worth over $20,119,402 and over the last 21 years he sold AXNX stock worth over $29,575,622. In addition, he makes $6,147,640 as Chief Executive Officer and Director at Axonics Inc.

Mr. Cohen AXNX stock SEC Form 4 insiders trading

Raymond has made over 37 trades of the Axonics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 103,896 units of AXNX stock worth $2,383,374 on 24 July 2024.

The largest trade he's ever made was exercising 103,896 units of Axonics Inc stock on 24 July 2024 worth over $2,383,374. On average, Raymond trades about 16,698 units every 54 days since 2004. As of 24 July 2024 he still owns at least 292,731 units of Axonics Inc stock.

You can see the complete history of Mr. Cohen stock trades at the bottom of the page.





Raymond Cohen biography

Raymond Wayne Cohen serves as Chief Executive Officer, Director of the Company. Mr. Cohen has extensive medical device experience, holding several Chair and Chief Executive Officer positions on the boards of publicly listed life sciences companies. Mr. Cohen is an accredited public company director having completed the UCLA certification program for public company directors. Since May 2006, Mr. Cohen has served as a member of the board of directors, Chair of the audit committee, compensation committee and nominating committee, and since November 2013 as Chair of the board of directors, of BioLife Solutions, Inc., (NASDAQ: BLFS), a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for human cells. From June 2013 to April 2020, Mr. Cohen served as a member of the board of directors, Chair of the compensation committee, member of the audit committee and member of the nominating and corporate governance committee of Spectrum Pharmaceuticals, Inc., (NASDAQ: SPPI), a developer and marketer of oncology and hematology drugs. From April 2016 to June 2017, Mr. Cohen served as a member of the board of directors and a member of the compensation and audit committees of publicly listed Zurich-based LifeWatch AG, a manufacturer and marketer of ambulatory electrocardiogram services, which was acquired by Biotelemetry Inc. (NASDAQ: BEAT), in July 2017. From June 2013 to December 2017, Mr. Cohen served as Chair of the board of directors of Lombard Medical, Inc., a manufacturer and marketer of abdominal aortic aneurysm stent graphs. From August 2010 to November 2012, Mr. Cohen served as Chief Executive Officer and as a member of the board of directors of Vessix Vascular, Inc., a developer of a novel renal denervation system used to treat uncontrolled hypertension, which was acquired by Boston Scientific Corporation. From 1997 to 2006,

What is the salary of Raymond Cohen?

As the Chief Executive Officer and Director of Axonics Inc, the total compensation of Raymond Cohen at Axonics Inc is $6,147,640. There are no executives at Axonics Inc getting paid more.



How old is Raymond Cohen?

Raymond Cohen is 61, he's been the Chief Executive Officer and Director of Axonics Inc since 2015. There are 4 older and 18 younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.

What's Raymond Cohen's mailing address?

Raymond's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.

Insiders trading at Axonics Inc

Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik, and Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.



What does Axonics Inc do?

axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.



What does Axonics Inc's logo look like?

Axonics Inc logo

Complete history of Mr. Cohen stock trades at Biolife Solutions Inc, Spectrum Pharmaceuticals, and Axonics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
24 Jul 2024 Raymond W Cohen
Chief Executive Officer
Option 103,896 $22.94 $2,383,374
24 Jul 2024
292,731
31 Jan 2024 Raymond W Cohen
Chief Executive Officer
Option 63,400 $67.88 $4,303,592
31 Jan 2024
223,996
31 Jan 2023 Raymond W Cohen
Chief Executive Officer
Option 61,968 $61.40 $3,804,835
31 Jan 2023
191,617
13 Jan 2023 Raymond W Cohen
Chief Executive Officer
Sale 40,736 $65.94 $2,686,132
13 Jan 2023
108,899
8 Aug 2022 Raymond W Cohen
Chief Executive Officer
Sale 44,000 $70.44 $3,099,360
8 Aug 2022
149,635
29 Mar 2022 Raymond W Cohen
Chief Executive Officer
Sale 50,000 $60.00 $3,000,000
29 Mar 2022
193,635
14 Mar 2022 Raymond W Cohen
Chief Executive Officer
Sale 50,000 $52.82 $2,641,000
14 Mar 2022
243,635
31 Jan 2022 Raymond W Cohen
Chief Executive Officer
Option 96,846 $47.43 $4,593,406
31 Jan 2022
374,750
9 Sep 2021 Raymond W Cohen
Chief Executive Officer
Sale 50,000 $77.11 $3,855,500
9 Sep 2021
234,607
8 Jun 2021 Raymond W Cohen
Chief Executive Officer
Sale 33,333 $60.00 $1,999,980
8 Jun 2021
284,607
18 May 2021 Raymond W Cohen
Chief Executive Officer
Sale 32,833 $55.00 $1,805,815
18 May 2021
317,940
10 May 2021 Raymond W Cohen
Chief Executive Officer
Sale 33,833 $53.74 $1,818,185
10 May 2021
350,773
31 Jan 2021 Raymond W Cohen
Chief Executive Officer
Option 33,334 $51.70 $1,723,368
31 Jan 2021
469,723
26 Jan 2021 Raymond W Cohen
Chief Executive Officer
Option 27,173 $53.15 $1,444,245
26 Jan 2021
424,231
7 Aug 2020 Raymond W Cohen
Chief Executive Officer
Sale 45,000 $42.07 $1,893,150
7 Aug 2020
397,058
15 Jul 2020 Raymond W Cohen
Chief Executive Officer
Sale 50,000 $39.45 $1,972,500
15 Jul 2020
442,058
13 Jul 2020 Raymond W Cohen
Chief Executive Officer
Sale 50,000 $38.42 $1,921,000
13 Jul 2020
492,058
16 Mar 2020 Raymond W Cohen
Chief Executive Officer
Option 41,224 $1.63 $67,195
16 Mar 2020
583,282
13 Feb 2020 Raymond W Cohen
Chief Executive Officer
Option 10,000 $1.63 $16,300
13 Feb 2020
552,058
30 Jan 2020 Raymond W Cohen
Chief Executive Officer
Option 16,667 $29.81 $496,843
30 Jan 2020
625,058
13 Jan 2020 Raymond W Cohen
Chief Executive Officer
Option 10,000 $1.63 $16,300
13 Jan 2020
618,391
19 Nov 2019 Raymond W Cohen
Chief Executive Officer
Sale 75,000 $20.74 $1,555,500
19 Nov 2019
608,391
6 Aug 2019 Raymond W Cohen
Chief Executive Officer
Buy 3,500 $30.41 $106,435
6 Aug 2019
683,391
12 Nov 2020 Raymond W Cohen
Director
Sale 5,625 $32.45 $182,531
12 Nov 2020
22,763
15 Aug 2019 Raymond W Cohen
Director
Option 5,357 $1.12 $6,000
15 Aug 2019
28,745
15 Jul 2019 Raymond W Cohen
Director
Option 5,357 $1.12 $6,000
15 Jul 2019
28,745
17 Jun 2019 Raymond W Cohen
Director
Option 5,357 $1.40 $7,500
17 Jun 2019
28,745
15 May 2019 Raymond W Cohen
Director
Sale 25,000 $17.59 $439,750
15 May 2019
23,388
15 Apr 2019 Raymond W Cohen
Director
Option 15,000 $2.06 $30,900
15 Apr 2019
53,388
20 Dec 2018 Raymond W Cohen
Director
Option 5,357 $1.26 $6,750
20 Dec 2018
38,388
21 Aug 2018 Raymond W Cohen
Director
Sale 10,000 $23.68 $236,800
21 Aug 2018
33,031
13 Aug 2018 Raymond W Cohen
Director
Sale 10,000 $19.70 $197,000
13 Aug 2018
43,031
30 May 2018 Raymond W Cohen
Director
Sale 10,000 $10.15 $101,500
30 May 2018
53,031
6 Feb 2017 Raymond W Cohen
Director
Option 17,857 $1.12 $20,000
6 Feb 2017
37,969
8 Aug 2014 Raymond W Cohen
Director
Buy 1,250 $2.48 $3,100
8 Aug 2014
8,466
20 May 2014 Raymond W Cohen
Director
Buy 4,000 $2.39 $9,560
20 May 2014
7,216
14 May 2018 Raymond W Cohen
Director
Sale 9,275 $18.32 $169,918
14 May 2018
28,850


Axonics Inc executives and stock owners

Axonics Inc executives and other stock owners filed with the SEC include: